JP2014501227A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501227A5
JP2014501227A5 JP2013543623A JP2013543623A JP2014501227A5 JP 2014501227 A5 JP2014501227 A5 JP 2014501227A5 JP 2013543623 A JP2013543623 A JP 2013543623A JP 2013543623 A JP2013543623 A JP 2013543623A JP 2014501227 A5 JP2014501227 A5 JP 2014501227A5
Authority
JP
Japan
Prior art keywords
concentration
fviii
solution
salt
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013543623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501227A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/071339 external-priority patent/WO2012079979A1/en
Publication of JP2014501227A publication Critical patent/JP2014501227A/ja
Publication of JP2014501227A5 publication Critical patent/JP2014501227A5/ja
Withdrawn legal-status Critical Current

Links

JP2013543623A 2010-12-16 2011-11-30 第ｖｉｉｉ因子水溶液 Withdrawn JP2014501227A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10195288 2010-12-16
EP10195288.5 2010-12-16
US201061424389P 2010-12-17 2010-12-17
US61/424,389 2010-12-17
PCT/EP2011/071339 WO2012079979A1 (en) 2010-12-16 2011-11-30 Aqueous factor viii solution

Publications (2)

Publication Number Publication Date
JP2014501227A JP2014501227A (ja) 2014-01-20
JP2014501227A5 true JP2014501227A5 (https=) 2015-01-22

Family

ID=43798550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013543623A Withdrawn JP2014501227A (ja) 2010-12-16 2011-11-30 第ｖｉｉｉ因子水溶液

Country Status (8)

Country Link
US (1) US20130345403A1 (https=)
EP (1) EP2651433A1 (https=)
JP (1) JP2014501227A (https=)
KR (1) KR20130125789A (https=)
CN (1) CN103282045A (https=)
CA (1) CA2821945A1 (https=)
RU (1) RU2013131911A (https=)
WO (1) WO2012079979A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105705516B (zh) * 2013-11-08 2019-11-01 杰特有限公司 浓缩von Willebrand因子或其络合物的方法
US11299533B2 (en) * 2017-06-23 2022-04-12 Takeda Pharmaceutical Company Limited Purification of factor VIII subspecies

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
US5605884A (en) * 1987-10-29 1997-02-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Factor VIII formulations in high ionic strength media
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media
CA2124690C (en) * 1992-10-02 2007-09-11 Thomas Osterberg Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
SE9503380D0 (sv) * 1995-09-29 1995-09-29 Pharmacia Ab Protein derivatives
DK1820516T3 (da) * 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
ES2411007T3 (es) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
CN1917861B (zh) * 2003-12-19 2012-03-21 诺和诺德医疗保健公司 因子vii多肽的稳定化固体组合物
PT2363414T (pt) * 2004-11-12 2022-08-04 Bayer Healthcare Llc Modificação de fviii direcionada a sítio
EP1871801A2 (en) * 2005-04-01 2008-01-02 Novo Nordisk Health Care AG Blood coagulation fviii analogues
AU2007245190B2 (en) * 2006-03-31 2011-07-21 Takeda Pharmaceutical Company Limited Pegylated factor VIII
PL2257311T3 (pl) * 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
ES2401965T3 (es) * 2009-02-19 2013-04-25 Novo Nordisk A/S Modificación de Factor VIII

Similar Documents

Publication Publication Date Title
UA117246C2 (uk) Похідні сульфамоїлпіроламіду та їх застосування як медикаментів для лікування гепатиту в
JP2016513069A5 (https=)
EA026667B9 (ru) Фармацевтическая композиция для лечения вируса гепатита с
CL2008003684A1 (es) Composicion farmaceutica que comprende una sal de aluminio, que tiene una relacion molar de aluminio a cloruro de 0,3:1 a 3:1 aproximadamente, ademas comprende zirconio; metodo de preparacion de la composicion; uso como antitranspirante.
UY32062A (es) Inhibidores de beta-secretasa
GB2438802A (en) Structure of the hepatitis C virus NS5A protein
HRP20221047T1 (hr) Derivat kinolina visoke čistoće i postupak za njegovu proizvodnju
EA201592198A1 (ru) Производные сульфамоилтиофенамида и их применение в качестве медикаментов для лечения гепатита b
EA201692443A1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
PH12015502775A1 (en) Amino triazine derivative and pharmaceutical composition comprising the same
EA201170958A1 (ru) Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, и способ ее получения
EA201171174A1 (ru) Ингибиторы репликации вируса гепатита c
HK1200812A1 (en) Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine
MX352721B (es) Método para formar juntas con soldadura por arco, en chaflán y juntas con soldadura por arco, en chaflán.
AR094918A1 (es) Compuestos de tetrahidropirrolotiazina como inhibidores de bace
RU2019138024A (ru) ХЛОРИДНАЯ СОЛЬ ПЕПТИДА TAT-NR2B9c, КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
EA201300604A1 (ru) Соединения, предназначенные для лечения респираторно-синцитиальных вирусных инфекций
EA201691759A1 (ru) Композиции и способы лечения легочной гипертензии
EA201100795A1 (ru) Фармацевтическая композиция эффективного ингибитора всг для перорального введения
IL292465B2 (en) Neuroactive compounds and methods of use thereof
ATE504569T1 (de) Neue salze von bazedoxifen
DOP2011000329A (es) Preparacion de solido
EA201490756A1 (ru) Разагилина цитрамид
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль